Development of a dual hormone artificial pancreas device
Advanced Development of Gemini-DHAP
This study is working on a new device called the Gemini-DHAP that automatically gives insulin and glucagon to help people with diabetes manage their blood sugar levels more easily and accurately.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sfc Fluidics, LLC NIH-funded |
| Lab location | 1 site (Fayetteville, United States) |
| Project ID | NIH-10892876 on NIH RePORTER |
What this research studies
This research focuses on creating a new device called the Gemini-DHAP, which is designed to automatically deliver both insulin and glucagon to individuals with diabetes. Using advanced microfluidic technology, the device will respond to real-time glucose readings from a continuous glucose monitor, ensuring precise hormone delivery. The project will involve extensive testing in laboratory and animal models to optimize the device's performance before moving towards clinical trials. Collaborations with medical and regulatory experts will help streamline the path to commercialization.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older with diabetes, particularly those who experience challenges in managing their blood glucose levels.
Not a fit: Patients who do not have diabetes or those who are not suitable candidates for hormone therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective management system for diabetes, improving blood sugar control and reducing complications for patients.
How similar studies have performed: Previous research on dual hormone delivery systems has shown promise, indicating that this approach could be a significant advancement in diabetes management.
Where this research is happening
Fayetteville, United States
- Sfc Fluidics, LLC — Fayetteville, United States (Active)
Researchers
- Principal investigator: Payne, Forrest — Sfc Fluidics, LLC
- Study coordinator: Payne, Forrest
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.